Moberg Pharma AB sell BiotechBee
Start price
13.05.24
/
70%
€2.37
Target price
31.05.26
€1.50
Performance (%)
-0.84%
End price
14.05.24
€2.35
Summary
This prediction ended on 14.05.24 with a price of €2.35. The SELL prediction by BiotechBee for Moberg Pharma AB closed nearly unchanged from the start price. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Moberg Pharma AB | 5.953% | 5.953% |
iShares Core DAX® | 1.776% | 3.175% |
iShares Nasdaq 100 | -1.037% | 1.869% |
iShares Nikkei 225® | -0.335% | 3.857% |
iShares S&P 500 | 0.854% | 2.567% |
According to BiotechBee what are the pros and cons of Moberg Pharma AB for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Moberg Pharma AB diskutieren
Sell mit Kursziel 1,5
In the thread Trading Moberg Pharma AB
Sell beendet